CapsoVision (NASDAQ:CV) vs. Utah Medical Products (NASDAQ:UTMD) Financial Analysis

CapsoVision (NASDAQ:CV – Get Free Report) and Utah Medical Products (NASDAQ:UTMD – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations.

Profitability

This table compares CapsoVision and Utah Medical Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CapsoVision -210.09% -160.23% -122.59%
Utah Medical Products 30.48% 8.78% 8.51%

Valuation & Earnings

This table compares CapsoVision and Utah Medical Products”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CapsoVision $13.55 million 26.98 -$25.32 million ($0.45) -15.16
Utah Medical Products $38.52 million 5.34 $11.29 million $3.34 21.63

Utah Medical Products has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

69.6% of Utah Medical Products shares are held by institutional investors. 2.3% of CapsoVision shares are held by company insiders. Comparatively, 8.0% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for CapsoVision and Utah Medical Products, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CapsoVision 1 1 2 0 2.25
Utah Medical Products 0 1 0 0 2.00

CapsoVision presently has a consensus target price of $9.50, suggesting a potential upside of 39.30%. Given CapsoVision’s stronger consensus rating and higher possible upside, equities research analysts clearly believe CapsoVision is more favorable than Utah Medical Products.

Risk & Volatility

CapsoVision has a beta of -2.34, meaning that its share price is 334% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500.

Summary

Utah Medical Products beats CapsoVision on 9 of the 13 factors compared between the two stocks.

About CapsoVision

(Get Free Report)

CapsoVision develops medical technology for capsule endoscopy, a method of examining the digestive tract using a swallowable camera. Its products are designed to help clinicians visualize the small intestine as part of diagnostic evaluation. The company’s CapsoCam Plus system uses a swallowable capsule with multiple cameras to capture panoramic images as it moves through the small intestine. Images are stored in the capsule and later retrieved for review using the company’s supporting hardware and software.

About Utah Medical Products

(Get Free Report)

Utah Medical Products, Inc. develops, manufactures and markets medical devices, with a focus on disposable products used in obstetrics, gynecology and neonatal care. Its offerings include devices and accessories for fetal monitoring, labor and delivery, newborn care and related clinical procedures. Founded in 1978 and headquartered in Midvale, Utah, the company also serves other areas of healthcare, including surgery and emergency care. Its products reach customers in the United States and international markets through a combination of direct sales and distribution channels.

Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.